Kyeong Kim
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Transcriptome-based high-frequency recurrence index predicts frequent recurrence in non-muscle-invasive bladder cancer after Bacillus Calmette-Guérin therapy.
Journal: BMC medicine
Published: September 03, 2025
A 23-Gene Prognostic Index Predicts Progression and Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer.
Journal: European urology
Published: October 27, 2023
COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype.
Journal: Investigative and clinical urology
Published: July 14, 2023
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone.
Journal: Investigative and clinical urology
Published: December 30, 2021
Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression.
Journal: International journal of molecular sciences
Published: November 02, 2021
Expression of RPL9 predicts the recurrence of non-muscle invasive bladder cancer with BCG therapy.
Journal: Urologic oncology
Published: October 19, 2021
Nutritional status assessed by the Controlling Nutritional Status (CONUT) score as a predictor of recurrence of urolithiasis.
Journal: Investigative and clinical urology
Published: January 21, 2021
A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy.
Journal: International journal of molecular sciences
Published: January 09, 2021
A high basal metabolic rate is an independent predictor of stone recurrence in obese patients.
Journal: Investigative and clinical urology
Published: September 23, 2020
Expression of phosphorylated p21-activated kinase 4 is associated with aggressive histologic characteristics and poor prognosis in patients with surgically treated renal cell carcinoma.
Journal: Investigative and clinical urology
Published: September 03, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026